Skip to main content
. 2016 Sep 5;2016(9):CD011511. doi: 10.1002/14651858.CD011511.pub2

NCT01728571.

Trial name or title LungVITamin D and OmegA‐3 Trial
Methods Double‐blind, placebo‐controlled RCT
Participants Adults aged 50 years or older
Interventions 2000 IU vitamin D3 orally daily (factorial design with marine omega‐3 fatty acids)
Outcomes Asthma exacerbations and symptoms in subgroup
Starting date July 2010
Contact information Prof Diane Gold, Brigham and Women's Hospital, Boston, USA
Notes